Patient Preference and Satisfaction With Insulin Glargine (Lantus) Solostar Pen vs Conventional Vial-Syringe Method of Lantus Injection Therapy in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT01226043 · COMPLETED
Trial details
- NCT number
- NCT01226043
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2012-05-01
- Enrollment
- 405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.